Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL BIOABSORBABLE SCAFFOLD INDUSTRY
2.1 Summary about Bioabsorbable Scaffold Industry
2.2 Bioabsorbable Scaffold Market Trends
2.2.1 Bioabsorbable Scaffold Production & Consumption Trends
2.2.2 Bioabsorbable Scaffold Demand Structure Trends
2.3 Bioabsorbable Scaffold Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Biodegradable Vascular Scaffold Material
4.2.2 Degradable Nerve Tissue Scaffolds
4.2.3 Corneal Tissue Engineering Scaffold
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospital
4.3.2 Research Institute
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Biodegradable Vascular Scaffold Material
5.2.2 Degradable Nerve Tissue Scaffolds
5.2.3 Corneal Tissue Engineering Scaffold
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospital
5.3.2 Research Institute
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Biodegradable Vascular Scaffold Material
6.2.2 Degradable Nerve Tissue Scaffolds
6.2.3 Corneal Tissue Engineering Scaffold
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospital
6.3.2 Research Institute
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Biodegradable Vascular Scaffold Material
7.2.2 Degradable Nerve Tissue Scaffolds
7.2.3 Corneal Tissue Engineering Scaffold
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospital
7.3.2 Research Institute
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Biodegradable Vascular Scaffold Material
8.2.2 Degradable Nerve Tissue Scaffolds
8.2.3 Corneal Tissue Engineering Scaffold
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospital
8.3.2 Research Institute
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Biodegradable Vascular Scaffold Material
9.2.2 Degradable Nerve Tissue Scaffolds
9.2.3 Corneal Tissue Engineering Scaffold
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospital
9.3.2 Research Institute
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Abbott Vascular
10.1.2 Arterial Remodeling Technologies
10.1.3 Biotronik
10.1.4 Elixir
10.1.5 ICON Interventional Systems
10.1.6 Kyoto Medical Planning Co., Ltd
10.1.7 Microport
10.1.8 OrbusNeich
10.1.9 REVA Medical, Inc
10.1.10 S3V Vascular Technologies
10.1.11 Sinomed
10.1.12 Tepha, Inc
10.1.13 Zorion Medical
10.1.14 Cardionovum
10.1.15 Reva
10.2 Bioabsorbable Scaffold Sales Date of Major Players (2017-2020e)
10.2.1 Abbott Vascular
10.2.2 Arterial Remodeling Technologies
10.2.3 Biotronik
10.2.4 Elixir
10.2.5 ICON Interventional Systems
10.2.6 Kyoto Medical Planning Co., Ltd
10.2.7 Microport
10.2.8 OrbusNeich
10.2.9 REVA Medical, Inc
10.2.10 S3V Vascular Technologies
10.2.11 Sinomed
10.2.12 Tepha, Inc
10.2.13 Zorion Medical
10.2.14 Cardionovum
10.2.15 Reva
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT